Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL6 | P41182 | 3/20 | 0.42 |
| ▸ | MAP4K3 | Q8IVH8 | 9/20 | 0.38 |
| ▸ | MAP4K1 | Q92918 | 9/20 | 0.38 |
| ▸ | IRAK4 | Q9NWZ3 | 9/20 | 0.38 |
| ▸ | PGR | P06401 | 3/20 | 0.37 |
| ▸ | PIN1 | Q13526 | 3/20 | 0.36 |
| ▸ | AURKA | O14965 | 1/20 | 0.35 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | MAP4K5 | Q9Y4K4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26624045 | 1.00 | BCL6 (0.42) | BCL6MAP4K3MAP4K1IRAK4PGR | |
| SCHEMBL26624012 | 0.91 | MAP4K1 (0.46) | BCL6MAP4K3MAP4K1IRAK4PGR | |
| SCHEMBL26624021 | 0.81 | MAP4K1 (0.56) | MAP4K3MAP4K1IRAK4AURKAMAP4K4 | |
| SCHEMBL31448272 | 0.81 | MAP4K1 (0.56) | MAP4K3MAP4K1IRAK4AURKAMAP4K4 | |
| SCHEMBL26624018 | 0.78 | MET (0.53) | — | |
| SCHEMBL26624025 | 0.73 | TYRO3 (0.55) | — | |
| SCHEMBL17792820 | 0.70 | BCL6 (0.49) | BCL6PIN1AURKACYP3A4 | |
| SCHEMBL4175833 | 0.70 | BCL6 (0.56) | BCL6PIN1 | |
| SCHEMBL30905173 | 0.70 | BCL6 (0.49) | BCL6AURKA | |
| SCHEMBL26624006 | 0.70 | WEE1 (0.52) | MAP4K3MAP4K1IRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4520757-A1 | COMPOUND INCLUDING 2,4-DIAMINOPYRIDINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | Korea Research Institute of Chemical Technology (KR) | 2025-03-12 | — | — | EP | disclosed |